We use umbilical cord mesenchymal stem cells (UCMSC) to treat diabetes by injecting into arteries near the pancreas or by IV. The immature stem cells can develop into pancreatic cells. The two cellular groups merge and may start forming more pancreatic tissue, which means, in the end, that the patient's body may produce more insulin, requires less shots (if any) , and also lower blood sugar levels.

For more information on stem cell therapy for diabetes, please complete a medical form